product development
risk stratification of preeclampsia
development of CALIbration framework
robust test
LC-MS PREeclampsia risk stratification test
endogenous metabolites
product risk stratification algorithm
well-established LC-MS test validation framework
classic bioanalysis validation framework
novel validation strategy
multiplex panel of endogenous compounds
preeclmapsia test
case of risk stratification products
robust quantification data
MDx
validation mass spectrometric assays
subsequent validation of novel mass spectrometric assays
suitable CALIbration framework
appropriate quantification strategy
set of endogenous occurring metabolites
perfect project
expertise
metabolite targets
innovative company
experienced researcher
key challenges
clinical support
key stakeholders
predictive metabolite biomarker profiles
regards
limitations
tests
perturbation
team of scientists
entrepreneurs
levels
candidate
Europe
format
optimal way
pre-eclampsia
researcherâ€™s doctoral dissertation
pregnancy
relevant background
Metabolomic Diagnostics
enterprise
following prerequisites
result
scope